STOCK TITAN
  1. Home
  2. Sec-filings
  3. VTYX
  4. [EFFECT] Ventyx Biosciences, Inc. SEC Filing

[EFFECT] Ventyx Biosciences, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 6, 2026
Accession Number: 0001193125-26-090533
Submission Type: POS AM
CIK: 0001851194
Company Name: Ventyx Biosciences, Inc.
File Number: 333-278584

Source: View Original Filing on SEC EDGAR

Ventyx Biosciences, Inc.

NASDAQ:VTYX

View VTYX Stock Overview →

VTYX Rankings

#2796 Ranked by Market Cap
N/A Ranked by Dividends

VTYX Latest News

Jan 7, 2026
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
Dec 2, 2025
Ventyx Provides Clinical and Corporate Updates
Dec 1, 2025
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nov 17, 2025
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London
Nov 6, 2025
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress

VTYX Latest SEC Filings

Mar 9, 2026
[EFFECT] Ventyx Biosciences, Inc. SEC Filing
Mar 5, 2026
[SCHEDULE 13D/A] Ventyx Biosciences, Inc. Amended Major Shareholder Report
Mar 4, 2026
[Form 4] Ventyx Biosciences, Inc. Insider Trading Activity
Mar 4, 2026
[Form 4] Ventyx Biosciences, Inc. Insider Trading Activity
Mar 4, 2026
[Form 4] Ventyx Biosciences, Inc. Insider Trading Activity

VTYX Stock Data

1.00B
68.73M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO